2009

Addressing the 4^th GAVI Partners' Forum, Andrew Witty, GlaxoSmithKline CEO, pays tribute to the catalytic role of the Advanced Market Commitment (AMC).

Despite the advantages of the 5-in-1 pentavalent vaccine, political will to drive widespread roll-out was lacking -- until GAVI support played a key role in changing market conditions.